First Drug for Treating Resistant Hypertension Approved

Aprocitentan (Tryvio®) brings hope to patients whose blood pressure simply won’t fall.


This past March, the U.S. Food & Drug Administration (FDA) approved aprocitentan for use in conjunction with other antihypertensive drugs in adults whose blood pressure is not adequately controlled with other medicatons.

To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access